-- Patent Extends Intellectual Property for its RTDS™ Technologies in combination with CRISPRs -- SAN DIEGO , April 8, 2019 /PRNewswire/ -- Cibus, a leader in advanced plant-breeding technologies, today announced it has been granted a ...
R3 Stem Cell is now offering a satisfaction guarantee for regenerative stem cell therapies performed at its nationwide Centers of Excellence. R3 wants patients to feel secure when they make a significant decision in selecting their stem cell ...
Integrations will Improve Genetic Disease Diagnosis and Coverage of Meaningful Literature ALAMEDA, Calif. and ANN ARBOR, Mich. , Apr. 2, 2019 /PRNewswire-PRWeb/ -- LifeMap Sciences , the leading integrated biomedical knowledgebase ...
In-person collection experience debuts at MaRS Health Innovation Week; pre-order now open for innovative live cell home collection kit in Canada . TORONTO , April 1, 2019 /CNW/ - Acorn Biolabs , a healthcare technology company ...
NEW YORK , April 1, 2019 /PRNewswire/ -- In the report the genomics market, the market is expected to reach US$ 32,995.3 Mn in 2025 from US$ 14,728.6 in 2017. The market is estimated to grow with a CAGR of 10.8% from 2017-2025.Read the ...
R3 Stem Cell is now offering $1000 off provider training for the April 26-27th, 2019 workshop for a limited time. The workshop provides an unparalleled experience for providers including both didactic sessions along with procedures on real ...
R3 Stem Cell, the nation's leader in regenerative therapies, has now achieved IRB approval for an amniotic and umbilical cord cell therapy study. The study is the only institutional review board approved protocol now in the United States. ...
WASHINGTON , March 27, 2019 /PRNewswire/ -- Although the pool of registered bone marrow donors has increased in recent years, a new study suggests that most people of southern-European and non-European descent are unlikely to have a suitable ...
A new study released today in STEM CELLS Translational Medicine (SCTM) indicates that donor age-dependent stem cell therapy could help optimize cell treatment strategies for clinical translation. DURHAM, N.C. , March 26, 2019 ...
Production Facility to be built in Jerusalem JERUSALEM , March 26, 2019 /PRNewswire/ -- Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications and rare diseases through gene therapy, ...
Alterations in the SCN2A gene influence the age of seizure onset and the severity of neurological impairments in affected children, aiding in the identification of suitable candidates for precision medicines and gene therapies in clinical trials , as ...
Assistant Prof. Ibrahim, Bitar, Department of Microbiology, Faculty of Medicine and University Hospital in Plzen, Charles University in Prague, Plzen, Czech Republic presents a research review elucidating CRISPR's molecular biology and its potential in addressing antimicrobial ...
Genetic predisposition towards greater muscle strength is associated with a longer lifespan and reduced vulnerability to common diseases, based on analysis of health and genome...
Stem cell therapy emerges as a viable and safe choice for individuals grappling with challenging traumatic spinal cord injuries , said experts ( ). Stem Cell Therapy’s Safety and Promising Benefits "This study documents the safety and ...
Researchers from the National Institutes of Health (NIH), US have identified over 275 million genetic variants that were not previously reported. This undiscovered pool of variants opens up new avenues for comprehending the genetic factors impacting ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers